Loading organizations...
ExSeed Health is a technology company.
ExSeed Health provides an at-home male fertility testing solution, accurately assessing reproductive health. Its CE-certified device pairs with a smartphone, delivering rapid, AI-driven analysis of sperm count, motility, and concentration to WHO standards in minutes. Users visualize sperm cells and access personalized lifestyle programs, with expert support.
Morten G. Ulsted, Emil Andersen, Daniel Gewecke Daugaard, and Torben Ulsted founded ExSeed Health in 2018. Morten G. Ulsted is CEO and Emil Andersen is Chief Science Officer. They identified a demand for discreet, accessible male fertility diagnostics, addressing male contribution to conception challenges.
The company serves men and couples navigating fertility journeys, offering convenient, private, and expert-guided options. ExSeed Health empowers individuals by demystifying male reproductive health, providing actionable insights, and guiding them toward improved outcomes. Its vision makes male fertility assessment and enhancement approachable and less stigmatized.
ExSeed Health has raised $4.4M across 2 funding rounds.
ExSeed Health has raised $4.4M in total across 2 funding rounds.
ExSeed Health is a health technology company specializing in male reproductive health, offering an at-home sperm analysis device powered by AI to assess sperm concentration and motility, alongside personalized lifestyle programs for fertility improvement[1][2][3]. It serves individuals and couples seeking convenient, private fertility insights without clinic visits, addressing male infertility—a factor in about half of infertility cases—through accessible testing and support[1][2]. Founded in 2017 with a Seed VC funding round, the company has demonstrated early growth in the burgeoning at-home fertility testing market, competing with players like Medical Electronic Systems (YO Home Sperm Test) and Mojo[1].
ExSeed Health emerged in 2017 from Denmark, initially developing medical devices and mobile apps focused on male infertility treatment[2]. The core idea—a state-of-the-art home device where users insert a semen sample into a glass slide and place a smartphone on top for AI-driven analysis of sperm quality—arose to make fertility testing private and accessible[1][2][3]. Founders' backgrounds are not detailed in available sources, but early traction centered on this innovative hardware-software combo, leading to headquarters relocation to London, England, at 6 Hooker's Road, and a Seed VC funding round[1][2]. This pivot from Denmark to the UK reflects strategic scaling in Europe's health tech ecosystem[1][2].
ExSeed Health stands out in the male fertility space through these key features:
ExSeed Health rides the wave of consumerized health tech, particularly at-home diagnostics amplified by AI and smartphones, amid rising infertility rates (affecting 1 in 6 couples globally) and demand for male-focused solutions long overshadowed by female fertility tools[1]. Timing aligns with post-pandemic shifts to telehealth and direct-to-consumer biotech, fueled by market forces like smartphone ubiquity and AI advancements in image analysis for biology[2][3]. By democratizing male fertility data, it influences the ecosystem—empowering proactive health decisions, reducing clinic overload, and spurring competition that elevates standards in reproductive health tech[1].
ExSeed Health is poised for expansion through product iterations (e.g., enhanced AI, telemedicine integrations) and potential Series A funding, capitalizing on the $5B+ fertility market's growth at 8-10% CAGR[1]. Trends like personalized medicine, wearable health data synergy, and global awareness campaigns will shape its path, potentially evolving it into a full-stack male reproductive platform. As at-home testing normalizes, ExSeed could redefine fertility journeys, turning early detection into family-building empowerment—much like its founding device brought clinic-grade insights home.
ExSeed Health has raised $4.4M in total across 2 funding rounds.
ExSeed Health's investors include Ozgur Tuncer, Dominic Perks, R42 Group, Trifork Labs, Friále, Hambro Perks, Y Combinator, Louis Beryl.
ExSeed Health has raised $4.4M across 2 funding rounds. Most recently, it raised $3.4M Seed Extension in February 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 15, 2022 | $3.4M Seed Extension | Ozgur Tuncer | Dominic Perks, R42 Group, Trifork Labs |
| Feb 1, 2020 | $1.0M Seed | Friále, Hambro Perks, Y Combinator, Louis Beryl |